These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 16425127

  • 1. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
    Weinberg A, Tierney C, Kendall MA, Bosch RJ, Patterson-Bartlett J, Erice A, Hirsch MS, Polsky B, AIDS Clinical Trials Group 360 Team.
    J Infect Dis; 2006 Feb 15; 193(4):488-93. PubMed ID: 16425127
    [Abstract] [Full Text] [Related]

  • 2. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov 15; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

  • 3. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.
    J Infect Dis; 2005 Mar 15; 191(6):873-80. PubMed ID: 15717261
    [Abstract] [Full Text] [Related]

  • 4. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A, Wohl DA, Barrett RJ, van der Horst C.
    J Infect Dis; 2001 Sep 15; 184(6):707-12. PubMed ID: 11517431
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.
    Tamarit A, Alberola J, Mir A, Benet I, Mira JV, Muñoz C, Galindo MJ, Navarro D.
    J Clin Virol; 2004 Apr 15; 29(4):308-14. PubMed ID: 15018860
    [Abstract] [Full Text] [Related]

  • 7. Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.
    Bronke C, Jansen CA, Westerlaken GH, De Cuyper IM, Miedema F, Tesselaar K, van Baarle D.
    Clin Immunol; 2007 Aug 15; 124(2):190-9. PubMed ID: 17556025
    [Abstract] [Full Text] [Related]

  • 8. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.
    J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR.
    Transpl Infect Dis; 2009 Dec 15; 11(6):519-28. PubMed ID: 19744286
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM.
    J Infect Dis; 2001 May 01; 183(9):1399-404. PubMed ID: 11294673
    [Abstract] [Full Text] [Related]

  • 11. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M, Keane N, McKinnon E, Phung S, Price P.
    HIV Med; 2007 Apr 01; 8(3):148-55. PubMed ID: 17461858
    [Abstract] [Full Text] [Related]

  • 12. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA, Maradona JA, de Oña M, Asensi V, Melón S, García-Alcalde ML, Rodríguez-Junquera M, Moreno-Torrico A, de Zárraga M.
    Med Clin (Barc); 1999 Sep 04; 113(6):205-9. PubMed ID: 10472608
    [Abstract] [Full Text] [Related]

  • 13. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S, Toma E, Cordeiro P, Ahmad R, Morisset R, Menezes J.
    J Med Virol; 2006 Apr 04; 78(4):431-9. PubMed ID: 16482539
    [Abstract] [Full Text] [Related]

  • 14. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
    Singh KP, Howard JL, Wild SP, Jones SL, Hoy J, Lewin SR.
    Clin Immunol; 2007 Aug 04; 124(2):200-6. PubMed ID: 17574925
    [Abstract] [Full Text] [Related]

  • 15. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Hsieh SM, Pan SC, Hung CC, Tsai HC, Chen MY, Chang SC.
    J Infect Dis; 2001 Dec 01; 184(11):1386-91. PubMed ID: 11709780
    [Abstract] [Full Text] [Related]

  • 16. Protective immunity to cytomegalovirus (CMV) retinitis in AIDS is associated with CMV-specific T cells that express interferon- gamma and interleukin-2 and have a CD8+ cell early maturational phenotype.
    Sinclair E, Tan QX, Sharp M, Girling V, Poon C, Natta MV, Jabs DA, Inokuma M, Maecker HT, Bredt B, Jacobson MA, Studies of Ocular Complications of AIDS Research Group.
    J Infect Dis; 2006 Dec 01; 194(11):1537-46. PubMed ID: 17083038
    [Abstract] [Full Text] [Related]

  • 17. Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy.
    Mihăilescu R, Arama V, Paraschiv S, Streinu-Cercel A, Oţelea D, Munteanu D, Iosipenco M, Chiotan C, Benea OE, Mărdărescu M, Rădulescu M, Hristea A, Ungurianu R, Aramă SS, Cercel AS, Călin R, Băicuş C.
    Rom J Intern Med; 2008 Dec 01; 46(4):305-11. PubMed ID: 19480296
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity.
    Springer KL, Weinberg A.
    J Antimicrob Chemother; 2004 Sep 01; 54(3):582-6. PubMed ID: 15282241
    [Abstract] [Full Text] [Related]

  • 19. Relationship of reconstituted adaptive and innate cytomegalovirus (CMV)-specific immune responses with CMV viremia in hematopoietic stem cell transplant recipients.
    Barron MA, Gao D, Springer KL, Patterson JA, Brunvand MW, McSweeney PA, Zeng C, Barón AE, Weinberg A.
    Clin Infect Dis; 2009 Dec 15; 49(12):1777-83. PubMed ID: 19911937
    [Abstract] [Full Text] [Related]

  • 20. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
    Jansen CA, Piriou E, De Cuyper IM, van Dort K, Lange JM, Miedema F, van Baarle D.
    Antivir Ther; 2006 Dec 15; 11(1):105-16. PubMed ID: 16518966
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.